Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Virology ; 522: 271-280, 2018 09.
Article in English | MEDLINE | ID: mdl-30056354

ABSTRACT

Viral RNA (vRNA) is found in mice inoculated with coxsackievirus-B4E2 (CV-B4E2). The CV-B4E2 infection of murine spleen cells in vitro is enhanced with CV-B4E2-infected mouse serum. It has been investigated whether monocyte/macrophages were targets of CV-B4E2 in mice. vRNA has been detected in spleen and bone marrow of infected animals. The levels of vRNA were higher in CD14+ cells than in CD14- spleen cells and in F4/80- cells than in F4/80+ spleen cells. Meanwhile, CD14+ cells and F4/80- cells were more permissive to CV-B4E2 in vitro and the infection was enhanced when the virus was mixed with immune serum. While CV-B4E2 infected BMDM cultures (98% F4/80+); however, the immune serum did not enhance the infection. In conclusion, CV-B4E2 infects monocytes (CD14+, F4/80-) and macrophages (CD14+, F4/80+) in vivo and immune serum can enhance the in vitro infection of these cells arising out of the spleen.


Subject(s)
Coxsackievirus Infections/virology , Enterovirus B, Human/growth & development , Macrophages/virology , Monocytes/virology , Animals , Antibody-Dependent Enhancement , Bone Marrow/virology , Disease Models, Animal , Mice , RNA, Viral/analysis , Spleen/virology
2.
Diabetes Metab Res Rev ; 33(7)2017 10.
Article in English | MEDLINE | ID: mdl-28719027

ABSTRACT

BACKGROUND: Coxsackieviruses B (CV-B) are enteroviruses that have been reported to play a role in the pathogenesis of type 1 diabetes. Enteroviral RNA was detected in the gut mucosa of patients. The mucosal immunity is an interconnected network; therefore, the response to enteroviruses possibly present in the gastrointestinal mucosa can be reflected by specific antibodies in the saliva. In the present study, the anti-CV-B neutralizing activity of saliva samples from patients with type 1 diabetes was investigated. METHODS: Saliva samples were collected from patients and controls of 3 countries, and plasma was obtained from some of them. The anti-CV-B activity of clinical samples was determined by neutralization of the cytopathic effect induced by challenging viruses in vitro and expressed as titre value. RESULTS: Overall prevalence and levels of anti-CV-B4 activity of saliva were higher in patients (n = 181) than in controls (n = 135; P = .0002; titre values ≥ 16: odds ratio = 4.22 95% CI: 1.90-9.38 P = .0002). It has been shown that IgA1 played a role in this activity. There was no correlation between the saliva and the plasma anti-CV-B4 neutralizing activity. The neutralizing activity of saliva against CV-B1, CV-B2, CV-B3, and CV-B5 existed rarely, if at all. Increased levels of anti-CV-B4 activity were observed all along a 4 year follow-up period in patients but not in matched controls (P = .01). CONCLUSION: There is an anti-CV-B4 activity in saliva of patients with type 1 diabetes that may be a useful marker to study the role of CV-B in the pathogenesis of the disease.


Subject(s)
Antibodies, Neutralizing/immunology , Coxsackievirus Infections/diagnosis , Diabetes Mellitus, Type 1/complications , Enterovirus B, Human/immunology , Saliva/immunology , Adolescent , Adult , Child , Child, Preschool , Coxsackievirus Infections/complications , Coxsackievirus Infections/immunology , Diabetes Mellitus, Type 1/virology , Female , Humans , Infant , Male , Young Adult
3.
Virulence ; 8(7): 1229-1244, 2017 10 03.
Article in English | MEDLINE | ID: mdl-28112573

ABSTRACT

INTRODUCTION: Although known as cytolytic viruses, group B coxackieviruses (CVB) are able to establish a persistent infection in vitro and in vivo. Viral persistence has been reported as a key mechanism in the pathogenesis of CVB-associated chronic diseases such as type 1 diabetes (T1D). The impact of CVB4 persistence on human pancreas ductal-like cells was investigated. METHODS: A persistent CVB4 infection was established in ductal-like cells. PDX-1 expression, resistance to CVB4-induced lysis and CAR expression were evaluated. The profile of cellular microRNAs (miRNAs) was investigated through miRNA-sequencing. Viral phenotypic changes were examined, and genomic modifications were assessed by sequencing of the viral genome. RESULTS: The CVB4 persistence in ductal-like cells was productive, with continuous release of infectious particles. Persistently infected cells displayed a resistance to CVB4-induced lysis upon superinfection and expression of PDX-1 and CAR was decreased. These changes were maintained even after virus clearance. The patterns of cellular miRNA expression in mock-infected and in CVB4-persistently infected ductal-like cells were clearly different. The persistent infection-derived virus (PIDV) was still able to induce cytopathic effect but its plaques were smaller than the parental virus. Several mutations appeared in various PIDV genome regions, but amino acid substitutions did not affect the predicted site of interaction with CAR. CONCLUSION: Cellular and viral changes occur during persistent infection of human pancreas ductal-like cells with CVB4. The persistence of cellular changes even after virus clearance supports the hypothesis of a long-lasting impact of persistent CVB infection on the cells.


Subject(s)
Coxsackievirus Infections/virology , Enterovirus B, Human/physiology , Pancreatic Ducts/cytology , Pancreatic Ducts/virology , Cell Line, Tumor , Coxsackievirus Infections/genetics , Coxsackievirus Infections/metabolism , Enterovirus B, Human/genetics , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , MicroRNAs/genetics , MicroRNAs/metabolism , Pancreas/metabolism , Pancreas/virology , Trans-Activators/genetics , Trans-Activators/metabolism , Virus Replication
4.
Clin Exp Immunol ; 187(3): 399-407, 2017 03.
Article in English | MEDLINE | ID: mdl-27790717

ABSTRACT

Type B coxsackievirus (CV-B) infections are involved frequently in the triggering of several autoimmune diseases such as myocarditis, dilated cardiomyopathy, pericarditis, pancreatitis, type 1 diabetes, encephalitis, thyroiditis or Sjögren's syndrome. Serological and virological evidence suggests that maternal infections during pregnancy can play a role in the appearance of these diseases in offspring. The current study aims to explore the effect of an in-utero CV-B infection on the fetal thymus, the central site for programming immunological self-tolerance. In this perspective, female Swiss albino mice were inoculated intraperitoneally or orally with the diabetogenic CV-B4 E2 strain at gestational days 10 or 17. Offspring were killed at different post-inoculation times, and their thymuses were analysed for evidence of infection and alterations in thymic T cell subsets. In-utero CV-B infection of the thymus was demonstrated during the course of vertical transmission, as attested by viral RNA and infectious virus detection in most analysed samples. No histopathological changes were evident. Thymic T cells were not depleted, despite being positive for viral RNA. As evidenced by flow cytometry analysis, CV-B infection of the fetal thymus induced significant changes of thymic T cell populations, particularly with maternal inoculation at gestational day 10. Altogether, these findings suggest that CV-B infection of the fetal thymus may play an important role in the genesis of autoimmune diseases.


Subject(s)
Autoimmune Diseases/virology , Coxsackievirus Infections/virology , Enterovirus B, Human/immunology , Thymus Gland/virology , Uterus/virology , Animals , Autoimmune Diseases/immunology , Coxsackievirus Infections/immunology , Female , Immune Tolerance/immunology , Infectious Disease Transmission, Vertical , Male , Mice , Pregnancy , RNA, Viral/genetics , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/virology , Thymus Gland/immunology , Uterus/immunology
5.
J Clin Virol ; 57(2): 161-4, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23478164

ABSTRACT

BACKGROUND: High-risk HPV (HR-HPV) are associated with the development of cervical cancer, the most common cancer in women in developing countries. Reliable diagnosis of HR-HPV infection combined with simple procedures to collect and store biological samples, could improve primary screening programs and vaccine strategies in these areas. OBJECTIVE: To evaluate HR-HPV detection in conventional and dried samples. STUDY DESIGN: The presence of HR-HPV in 31 women in Republic of Congo (Central Africa) has been investigated by using standard cervical samples and dried cervical samples collected on filter paper and vaginal tampons. The detection of HPV DNA was performed in the Laboratory of virology in Lille (France) by using Hybrid capture 2 and HPV 16/18/45 Probe Set Test. RESULTS: 22 standard samples were found positive for the detection of HR-HPV (71%). HPV 16/18/45 was displayed in 15 out of 22 samples positive for HR-HPV (68%). The correlations between HPV detection by using standard samples and samples dried on filter paper and dried tampons were 90.3% (kappa = 0.77) and 80.6% (kappa = 0.5) respectively. The sensitivity and the specificity of HPV detection reached 91% and 89%, respectively, with samples dried on filter paper and were 86% and 67%, respectively, for dried tampons compared with standard samples. CONCLUSION: Dried cervical samples and dried vaginal tampons can represent an alternative to conventional sampling to reduce barriers to large screening programs in developing countries and to facilitate storage and transport to reference centers.


Subject(s)
Cervix Uteri/virology , Filtration/methods , Menstrual Hygiene Products/virology , Papillomaviridae/genetics , Papillomaviridae/isolation & purification , Papillomavirus Infections/diagnosis , Specimen Handling/methods , Uterine Cervical Neoplasms/diagnosis , Congo , DNA, Viral/analysis , DNA, Viral/genetics , Desiccation , Female , Human papillomavirus 16/genetics , Human papillomavirus 16/isolation & purification , Human papillomavirus 18/genetics , Human papillomavirus 18/isolation & purification , Humans , Papillomaviridae/classification , Papillomavirus Infections/epidemiology , Papillomavirus Infections/virology , Risk , Sensitivity and Specificity , Uterine Cervical Neoplasms/epidemiology , Uterine Cervical Neoplasms/virology
6.
J Med Virol ; 85(5): 880-7, 2013 May.
Article in English | MEDLINE | ID: mdl-23408519

ABSTRACT

The role of enteroviruses in type 1 diabetes has long been suspected. A lower risk of type 1 diabetes is associated with breastfeeding, which could be due to a protective effect against enteroviruses. The neutralizing activity of breast milk against CVB4, a representative of enteroviruses was investigated in this study in vitro. Breast milk was cytotoxic to Hep-2 cells up to a dilution of 1/32, whereas the aqueous fraction obtained after centrifugation was not cytotoxic; although it inhibited the cytopathic effect of CVB4 on Hep-2 cell monolayers. The anti-CVB4 neutralizing activity of aqueous fractions of breast milk from 49 donors living in Northern France and 15 donors living in Congo, where enteroviral infections are more prevalent, were determined. The levels of colostrum activity expressed as titre ranged from <2 to 32 in 36% of the donors from France whereas they were >128 in every donor from Congo. Pasteurized colostrum had a lower anti-CVB4 activity compared to fresh samples (P < 0.0001, n = 49). The treatment of colostrum samples with jacalin-coated beads that bind specifically to human IgA, showed that IgA plays a role in anti-CVB4 activity. There was no correlation between the neutralizing activities of breast milk and serum (P = 0.37, n = 25). The current study showed that the variations in anti-CVB4 activity in breast milk can be attributed to environmental and living conditions. Whether a low protective activity of breast milk against enteroviruses expose newborns to a higher risk of type 1 diabetes deserves further investigation.


Subject(s)
Antibodies, Neutralizing/immunology , Enterovirus B, Human/immunology , Immunoglobulin A/immunology , Milk, Human/immunology , Congo , Female , France , Humans , Neutralization Tests , Plasma/immunology
7.
Microbes Infect ; 15(1): 18-27, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23108316

ABSTRACT

Coxsackievirus B4 (CV-B4), in presence of antibodies and through a specific viral receptor CAR and Fcγ receptors II and III, can infect monocytes which results in interferon-α synthesis. The antibody-dependent enhancement of CV-B4 infection in the human monocytic-like THP-1 cell line has been investigated. The preincubation of CV-B4 with human plasma or human polyvalent immunoglobulins enhanced the infection of phorbol-myristate-acetate (PMA)-activated THP-1 cell cultures. CV-B4 replicated in these cells as demonstrated by the intracellular detection of infectious particles, viral protein VP1 (immunofluorescence), positive and negative viral RNA (RT-PCR). The viability of infected and control cell cultures was not different up to 20 days post-infection. Activated cell cultures inoculated with CV-B4 harbored intracellular RNA up to 14 days post-infection and produced IFNα that was detected by intracellular immunofluorescence staining as soon as 4 h post-infection with a maximum at 48 h post-infection and by RT-PCR all along the experiment. Together, these data demonstrate that PMA-activated THP-1 cells can be infected with CV-B4, can produce IFNα as a result of interactions between the virus, antibodies and specific receptors. This cellular model can be used to investigate further the mechanism and the result of the antibody-dependent enhancement of CV-B4 infection.


Subject(s)
Enterovirus B, Human/immunology , Immunoglobulins/pharmacology , Monocytes/immunology , Monocytes/virology , Cells, Cultured , Coxsackie and Adenovirus Receptor-Like Membrane Protein/immunology , Coxsackievirus Infections/immunology , Coxsackievirus Infections/virology , Enterovirus B, Human/pathogenicity , Host-Pathogen Interactions/drug effects , Humans , Interferon-alpha/biosynthesis , Interferon-alpha/immunology , Intracellular Space/metabolism , Intracellular Space/virology , Monocytes/drug effects , Monocytes/metabolism , Receptors, IgG/immunology , T-Lymphocytes, Helper-Inducer/immunology , Tetradecanoylphorbol Acetate/analogs & derivatives , Tetradecanoylphorbol Acetate/pharmacology
8.
Clin Exp Immunol ; 168(1): 39-46, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22385235

ABSTRACT

Thymus dysfunction, especially immune suppression, is frequently associated with various virus infections. Whether viruses may disturb the thymus function and play a role in the pathogenesis of autoimmune diseases is an open issue. Enteroviruses, especially Coxsackievirus B4 (CV-B4), have been largely suggested as potential inducers or aggravating factors of type 1 diabetes (T1D) pathogenesis in genetically predisposed individuals. Several pathogenic mechanisms of enterovirus-induced T1D have been suggested. One of these mechanisms is the impairment of central self-tolerance due to viral infections. Coxsackievirus-B4 is able to infect murine thymus in vitro and in vivo and to infect human thymus in vitro. Thymic epithelial cells and thymocytes are targets of infection with this virus, and several abnormalities, especially disturbance of maturation/differentiation processes, were observed. Altogether, these data suggest that CV-B infection of thymus may be involved in the pathogenesis of T1D. Further investigations are needed to explore this hypothesis.


Subject(s)
Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/virology , Thymus Gland/immunology , Thymus Gland/virology , Animals , Autoimmune Diseases/virology , Coxsackievirus Infections/immunology , Coxsackievirus Infections/virology , Diabetes Mellitus, Type 1/genetics , Enterovirus B, Human/immunology , Enterovirus B, Human/pathogenicity , Genetic Predisposition to Disease , Humans , Mice , Self Tolerance/immunology , T-Lymphocytes/immunology , T-Lymphocytes/virology , Thymocytes/immunology , Thymocytes/virology
9.
Clin Exp Immunol ; 168(1): 47-51, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22385236

ABSTRACT

Type 1 diabetes results from an interaction between genetic and environmental factors. Coxsackieviruses B (CV-B) are major environmental candidates, as suggested by epidemiological and experimental studies. The mechanisms leading to the disease involve interactions between the virus, host target tissue (pancreas) and the immune system. The infection of target cells with viruses can be prevented by antibodies. Conversely, the infection can be enhanced by antibodies. The antibody-dependent enhancement (ADE) of infection has been described with various viruses, especially Picornaviruses. In mice infected with CV-B3 this phenomenon resulted in an extended inflammatory reaction and myocarditis. In the human system non-neutralizing antibodies can increase the infection of monocytes with CV-B4 and stimulate the production of interferon (IFN)-α by these cells in vitro. CV-B4/immunoglobulin (Ig)G immune complexes interacted with a specific viral receptor [Coxsackievirus and adenovirus receptor (CAR)] and with IgG Fc fraction receptors (FcγRII and FcγRIII) at the surface of monocytes. The virus-antibody complexes are internalized (CAR) and receptors for the Fc of IgG (FcγRII and FcγRIII). Such antibodies have been detected in patients with type 1 diabetes and they could be responsible for the presence of enteroviral RNA and IFN-α in peripheral blood mononuclear cells (PBMC) of these individuals. The target of enhancing antibodies has been identified as the VP4 protein, which allowed the detection of these antibodies by enzyme-linked immunosorbent assay (ELISA). It cannot be excluded that antibodies enhancing the infection with CV-B may play a role in the pathogenesis of type 1 diabetes, induced or aggravated by these viruses. They can cause a viral escape from the immune response and may participate in the spreading of viruses to ß cells. Whether enhancing antibodies raised against VP4 can play a role in iterative homologous and/or heterologous CV-B infections and in the persistence of viruses within the host deserves further study.


Subject(s)
Antibodies, Viral/immunology , Antibody-Dependent Enhancement , Coxsackievirus Infections/immunology , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/virology , Enterovirus B, Human/immunology , Animals , Antibodies, Viral/blood , Coxsackievirus Infections/virology , Humans , Immunoglobulin G/immunology , Immunoglobulin G/metabolism , Insulin-Secreting Cells/immunology , Insulin-Secreting Cells/virology , Interferon-gamma/biosynthesis , Mice , RNA, Viral/blood
10.
Diabetes Metab Res Rev ; 25(7): 591-603, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19621354

ABSTRACT

The role of enteroviruses, in particular type B coxsackieviruses (CV-B), in type 1 diabetes (T1D) pathogenesis is supported by epidemiological, clinical and experimental observations.The investigation of T1D pathogenesis benefits from the contribution of animal models called spontaneously diabetic. Among these animals the non-obese diabetic (NOD) mouse and the bio-breeding diabetes-prone (BBDP) rat present a genetic susceptibility manifested by the expression of an autoimmune diabetes similar to the pathology observed in human beings. Other models whose genetic predisposition is less known are of considerable contribution as well. Numerous major observations relative to several aspects of T1D pathogenesis in the context of CV-B infections, such as susceptibility, diabetogenicity, pancreatotropism, mechanisms of beta cells destruction and others, have been deduced thanks to investigations with animal models. Despite their limits, these models are necessary in improving our knowledge of the role of enteroviruses, like CV-B4, in the pathogenesis of T1D, and the recent advances ensuing from their contribution may have important therapeutic and preventive spin-offs.


Subject(s)
Coxsackievirus Infections/complications , Diabetes Mellitus, Type 1/etiology , Disease Models, Animal , Enterovirus B, Human/pathogenicity , Animals , Humans , Mice , Rats
11.
Pathol Biol (Paris) ; 57(3): 258-67, 2009 May.
Article in French | MEDLINE | ID: mdl-19179019

ABSTRACT

Most of enterovirus infections are benign and the rate of mortality is low in countries with temperate climates. But since the late 1990s, Enterovirus 71 (EV-71) has become much more aggressive in Asian countries, with the outcome of a neurogenic pulmonary oedema syndrome and it is responsible for huge epidemics. The virological diagnosis rely upon viral isolation and identification by sero-neutralization, and upon the detection of specific IgM by ELISA and viral RNA by RT-PCR. There is no specific treatment to fight this virus, but innovative strategies, especially based on interfering RNA, are under investigation.


Subject(s)
Enterovirus Infections/epidemiology , Asia/epidemiology , Enterovirus/genetics , Enterovirus/immunology , Enterovirus/isolation & purification , Enterovirus Infections/mortality , Enterovirus Infections/prevention & control , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin M/blood , Pulmonary Edema/epidemiology , Pulmonary Edema/virology , RNA, Viral/genetics , RNA, Viral/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction
12.
Ann Biol Clin (Paris) ; 66(5): 485-92, 2008.
Article in French | MEDLINE | ID: mdl-18957336

ABSTRACT

First seen in Ghana and Indonesia in the early 70's, acute haemorrhagic conjunctivitis or "Apollo 11" disease is an eye infection caused by Enterovirus type 70 (EV70). The disease appeared to be a highly contagious conjunctivitis which spread rapidly all over the world. EV70 has been considered as an emerging virus and was classified as a new Enterovirus. No human or animal virus genetically similar to EV70 was known before the sudden outcome of the disease in Ghana, West Africa. EV70 appeared as a pretty demonstrative example of virus emergence and virus spreading. Studies of virus genetic mutations emphasized the variations of RNA virus within a short time period. The current review presents the EV70 infection and the genetic profile of the virus from its emergence to nowadays.


Subject(s)
Conjunctivitis, Acute Hemorrhagic , Enterovirus D, Human , Enterovirus Infections , Africa/epidemiology , Asia/epidemiology , Conjunctivitis, Acute Hemorrhagic/diagnosis , Conjunctivitis, Acute Hemorrhagic/epidemiology , Conjunctivitis, Acute Hemorrhagic/virology , Diagnosis, Differential , Enterovirus D, Human/genetics , Enterovirus D, Human/isolation & purification , Enterovirus D, Human/physiology , Enterovirus Infections/diagnosis , Enterovirus Infections/epidemiology , Enterovirus Infections/virology , Europe/epidemiology , Genes, Viral/genetics , Genetic Variation , Humans , Mutation , Reverse Transcriptase Polymerase Chain Reaction
13.
Ann Biol Clin (Paris) ; 64(5): 467-9, 2006.
Article in French | MEDLINE | ID: mdl-17040878

ABSTRACT

We report a case of a 15-year-old young man who was admitted for an acute hepatitis. Virological assessment showed both IgM anti-EBV and IgM anti-hepatitis A. IgG anti-EBNA and clinical history allowed to rule out the hypothesis of a recent EBV infection and confirmed the diagnosis of acute hepatitis A infection.


Subject(s)
Hepatitis A virus/immunology , Hepatitis A/diagnosis , Herpesvirus 4, Human/immunology , Immunoglobulin M/analysis , Acute Disease , Adolescent , Emergencies , Follow-Up Studies , Hepatitis A/immunology , Humans , Intensive Care Units , Male , Time Factors
14.
Ann Biol Clin (Paris) ; 64(5): 497-9, 2006.
Article in French | MEDLINE | ID: mdl-17040883

ABSTRACT

Parvovirus B19 classically causes erythema infectiosum in children, febrile arthralgia or acute erythroblastopenia in adult. The clinical spectrum of adult primary infection is sometimes misleading. We report an observation of an acute rheumatoid-like arthritis following primary parvovirus B19 infection in a 42-year-old woman.


Subject(s)
Arthritis, Infectious , Parvoviridae Infections , Parvovirus B19, Human , Adult , Analgesics/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Infectious/diagnosis , Arthritis, Infectious/drug therapy , Female , Genes, Viral , Humans , Immunoglobulin M/blood , Parvoviridae Infections/diagnosis , Parvoviridae Infections/drug therapy , Parvovirus B19, Human/genetics , Parvovirus B19, Human/immunology , Polymerase Chain Reaction
15.
J Immunol ; 144(6): 2152-8, 1990 Mar 15.
Article in English | MEDLINE | ID: mdl-1690236

ABSTRACT

Monocyte/macrophages (MM) were isolated from HIV-1 seronegative individuals, infected with HIV-1 and examined for their ability to infect autologous T lymphocytes with and without concomitant presentation of exogenous Ag. HIV-1-infected MM presented tetanus toxin (TT) and streptokinase to T cells (as measured by [3H]thymidine incorporation) comparable to presentation by uninfected MM. In these studies, it was observed that HIV-1-infected MM without additional exogenous Ag stimulated autologous T lymphocytes, however, to a lesser degree than with TT and streptokinase. Virus production in T cells appeared to be relative to the degree of stimulation with the highest levels of stimulation and infection observed when T cells were exposed to HIV-1-infected TT-presenting MM. Studies were carried out to examine some of the restricting elements in MM-mediated infection of T lymphocytes with and without TT presentation. Antibodies to CD4, as well as soluble immunopurified gp120, blocked cell-mediated infection indicating that infection of T cells was through the CD4 molecule as has been demonstrated with cell-free virus. In addition, soluble gp120 inhibited Ag presentation by HIV-1-infected and uninfected MM. mAb to MHC class II Ag HLA-DR and -DP blocked T cell infection by HIV-1-infected MM with and without presentation of TT. No effect was observed with mAb to MHC class I Ag. These results indicate that virus transmission to T lymphocytes can be mediated by HIV-1-infected MM and that these cells maintain their function as APC. Activation of T cells appears to be important in the process of T cell infection in this system inasmuch as antibodies that block Ag presentation and thus a T cell proliferative signal inhibit infection.


Subject(s)
HIV Infections/microbiology , Macrophages/microbiology , Monocytes/microbiology , Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/microbiology , Binding, Competitive , CD4 Antigens/physiology , HIV Envelope Protein gp120/metabolism , HIV-1/growth & development , Humans , In Vitro Techniques , Interleukin-2/pharmacology , RNA-Directed DNA Polymerase/analysis , Receptors, Virus/physiology , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...